NCT03948529 2025-09-30
REGALIA
University Hospital, Lille
Phase 2 Terminated
Clinical Trials
10 trialsNCT02446145 2024-03-29
DELTA
Technische Universität Dresden
Phase 2 Terminated
NCT01550185 2022-07-22
Eltrombopag Olamine in Treating Patients With Relapsed/Refractory Acute Myeloid Leukemia
Roswell Park Cancer Institute
Phase 1 Terminated
NCT01113502 2021-08-05
Eltrombopag in Elderly Acute Myelogenous Leukemia (AML)
Abramson Cancer Center at Penn Medicine
Phase 1/2 Terminated
NCT01656252 2020-11-03
PrE0901
PrECOG, LLC.
Phase 1/2 Terminated
NCT02010645 2020-01-02
Eltrombopag With Decitabine in Advanced Myelodysplastic Syndrome (MDS)
M.D. Anderson Cancer Center
Phase 2 Terminated
NCT01484314 2017-03-15
Eltrombopag for Thrombocytopenia in Patients With Relapsed Multiple Myeloma
Dana-Farber Cancer Institute
Phase 2 Terminated
NCT01500538 2016-02-15
VEIL
Peter MacCallum Cancer Centre, Australia
Phase 2 Terminated
NCT01397149 2015-05-28
Eltrombopag in Thrombocytopenic Chronic Lymphocytic Leukemia (CLL) Patients (CLL2S Study of GCLLSG)
University of Ulm
Phase 1/2 Terminated
NCT01491594 2014-04-02
Eltrombopag for the Prevention of Chemotherapy Induced Thrombocytopenia
Duke University
Phase 1 Terminated